Omeros (OMER) Stock Forecast, Price Target & Predictions
OMER Stock Forecast
Omeros stock forecast is as follows: an average price target of $2.00 (represents a -80.60% downside from OMER’s last price of $10.31) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
OMER Price Target
OMER Analyst Ratings
Hold
Omeros Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 08, 2022 | UBS | $2.00 | $2.02 | -1.23% | -80.60% |
Omeros Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $10.31 | $10.31 | $10.31 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 08, 2022 | UBS | Neutral | Downgrade |
Omeros Financial Forecast
Omeros Revenue Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Sep 09 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | $-79.89M | $30.00M | $28.82M | $21.06M | $10.63M | $26.11M | $13.53M | $23.54M | $33.42M | $29.86M | $26.75M | $21.78M | $1.59M | $12.26M | $7.42M | $388.00K | $100.00K | $1.09M | $1.50M | $1.24M | $378.00K | $442.00K |
Avg Forecast | - | - | - | $2.79M | $10.21M | $66.92M | $27.96M | $24.27M | $20.53M | $14.91M | $20.82M | $17.10M | $30.43M | $31.74M | $28.29M | $24.52M | $23.18M | $1.59M | $12.98M | $5.91M | $479.29K | $83.33K | $1.07M | $1.54M | $1.61M | $365.81K | $489.78K |
High Forecast | - | - | - | $2.79M | $10.21M | $66.92M | $27.96M | $24.27M | $20.53M | $14.91M | $20.82M | $17.10M | $30.43M | $31.74M | $28.29M | $24.52M | $23.18M | $1.91M | $15.57M | $7.09M | $575.15K | $100.00K | $1.28M | $1.85M | $1.93M | $438.97K | $587.74K |
Low Forecast | - | - | - | $2.79M | $10.21M | $66.92M | $27.96M | $24.27M | $20.53M | $14.91M | $20.82M | $17.10M | $30.43M | $31.74M | $28.29M | $24.52M | $23.18M | $1.27M | $10.38M | $4.73M | $383.43K | $66.67K | $854.10K | $1.23M | $1.29M | $292.64K | $391.83K |
# Analysts | - | - | - | 16 | 10 | 9 | 9 | 13 | 9 | 9 | 15 | 9 | 9 | 16 | 8 | 10 | 16 | 18 | 19 | 8 | 8 | 13 | 14 | 16 | 11 | 11 | 16 |
Surprise % | - | - | - | - | - | -1.19% | 1.07% | 1.19% | 1.03% | 0.71% | 1.25% | 0.79% | 0.77% | 1.05% | 1.06% | 1.09% | 0.94% | 1.00% | 0.94% | 1.26% | 0.81% | 1.20% | 1.03% | 0.97% | 0.77% | 1.03% | 0.90% |
Forecast
Omeros EBITDA Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Sep 09 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 16 | 10 | 9 | 9 | 13 | 9 | 9 | 15 | 9 | 9 | 16 | 8 | 10 | 16 | 18 | 19 | 8 | 8 | 13 | 14 | 16 | 11 | 11 | 16 |
EBITDA | - | - | - | $-49.54M | $-34.27M | $285.89M | $-17.48M | $-23.33M | $-29.80M | $-33.04M | $-39.03M | $-26.90M | $-22.73M | $-22.89M | $-10.31M | $-8.47M | $-18.37M | $-27.01M | $-12.31M | $-19.11M | $-17.66M | $-15.89M | $-9.84M | $-8.31M | $-6.08M | $-6.08M | $-3.27M |
Avg Forecast | - | - | - | $808.22K | $-42.96M | $19.37M | $8.09M | $7.02M | $-29.80M | $4.32M | $6.03M | $4.95M | $-11.03M | $9.19M | $8.19M | $7.10M | $-19.07M | $-27.01M | $-12.99M | $-14.22M | $-21.02M | $-12.71M | $-9.58M | $-8.54M | $-7.48M | $-5.88M | $-3.63M |
High Forecast | - | - | - | $808.22K | $-34.37M | $19.37M | $8.09M | $7.02M | $-23.84M | $4.32M | $6.03M | $4.95M | $-8.82M | $9.19M | $8.19M | $7.10M | $-15.26M | $-21.60M | $-10.40M | $-11.38M | $-16.82M | $-10.17M | $-7.67M | $-6.83M | $-5.99M | $-4.71M | $-2.90M |
Low Forecast | - | - | - | $808.22K | $-51.56M | $19.37M | $8.09M | $7.02M | $-35.76M | $4.32M | $6.03M | $4.95M | $-13.23M | $9.19M | $8.19M | $7.10M | $-22.89M | $-32.41M | $-15.59M | $-17.07M | $-25.22M | $-15.25M | $-11.50M | $-10.25M | $-8.98M | $-7.06M | $-4.35M |
Surprise % | - | - | - | -61.30% | 0.80% | 14.76% | -2.16% | -3.32% | 1.00% | -7.66% | -6.48% | -5.44% | 2.06% | -2.49% | -1.26% | -1.19% | 0.96% | 1.00% | 0.95% | 1.34% | 0.84% | 1.25% | 1.03% | 0.97% | 0.81% | 1.03% | 0.90% |
Forecast
Omeros Net Income Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Sep 09 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 16 | 10 | 9 | 9 | 13 | 9 | 9 | 15 | 9 | 9 | 16 | 8 | 10 | 16 | 18 | 19 | 8 | 8 | 13 | 14 | 16 | 11 | 11 | 16 |
Net Income | - | - | - | $33.31M | $-37.46M | $-110.11M | $-22.70M | $-28.59M | $-35.09M | $-37.27M | $-38.46M | $-33.29M | $-29.03M | $-29.23M | $-16.46M | $-14.45M | $-24.34M | $-30.05M | $-15.09M | $-20.54M | $-18.67M | $-16.64M | $-10.49M | $-8.89M | $-6.54M | $-6.66M | $-3.92M |
Avg Forecast | $-44.23M | $-40.85M | $-65.92M | $-32.33M | $-41.38M | $10.51M | $-27.31M | $-33.48M | $-35.09M | $-40.05M | $-28.16M | $-33.96M | $-14.09M | $-23.18M | $-21.90M | $-26.85M | $-25.28M | $-30.05M | $-15.93M | $-15.28M | $-22.23M | $-13.31M | $-10.22M | $-9.14M | $-8.05M | $-6.44M | $-4.34M |
High Forecast | $-31.10M | $-40.85M | $-65.92M | $-32.33M | $-33.10M | $10.51M | $-27.31M | $-33.48M | $-28.07M | $-40.05M | $-28.16M | $-33.96M | $-11.27M | $-23.18M | $-21.90M | $-26.85M | $-20.23M | $-24.04M | $-12.74M | $-12.23M | $-17.78M | $-10.65M | $-8.18M | $-7.31M | $-6.44M | $-5.15M | $-3.47M |
Low Forecast | $-57.37M | $-40.85M | $-65.92M | $-32.33M | $-49.66M | $10.51M | $-27.31M | $-33.48M | $-42.11M | $-40.05M | $-28.16M | $-33.96M | $-16.91M | $-23.18M | $-21.90M | $-26.85M | $-30.34M | $-36.06M | $-19.11M | $-18.34M | $-26.67M | $-15.98M | $-12.26M | $-10.97M | $-9.66M | $-7.73M | $-5.21M |
Surprise % | - | - | - | -1.03% | 0.91% | -10.48% | 0.83% | 0.85% | 1.00% | 0.93% | 1.37% | 0.98% | 2.06% | 1.26% | 0.75% | 0.54% | 0.96% | 1.00% | 0.95% | 1.34% | 0.84% | 1.25% | 1.03% | 0.97% | 0.81% | 1.03% | 0.90% |
Forecast
Omeros SG&A Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Sep 09 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 16 | 10 | 9 | 9 | 13 | 9 | 9 | 15 | 9 | 9 | 16 | 8 | 10 | 16 | 18 | 19 | 8 | 8 | 13 | 14 | 16 | 11 | 11 | 16 |
SG&A | - | - | - | $12.20M | $10.96M | $-5.63M | $20.86M | $21.56M | $18.05M | $17.90M | $19.82M | $16.93M | $18.04M | $16.13M | $16.93M | $16.93M | $14.63M | $10.93M | $12.47M | $11.11M | $8.99M | $3.77M | $3.99M | $2.32M | $2.26M | $1.72M | $1.28M |
Avg Forecast | - | - | - | $2.55M | $9.32M | $61.07M | $25.51M | $22.15M | $18.05M | $13.61M | $19.00M | $15.60M | $8.75M | $28.97M | $25.82M | $22.38M | $15.19M | $1.45M | $11.84M | $5.39M | $437.39K | $76.05K | $974.29K | $1.40M | $1.47M | $333.82K | $446.96K |
High Forecast | - | - | - | $2.55M | $9.32M | $61.07M | $25.51M | $22.15M | $21.66M | $13.61M | $19.00M | $15.60M | $10.50M | $28.97M | $25.82M | $22.38M | $18.23M | $1.74M | $14.21M | $6.47M | $524.87K | $91.25K | $1.17M | $1.69M | $1.76M | $400.59K | $536.36K |
Low Forecast | - | - | - | $2.55M | $9.32M | $61.07M | $25.51M | $22.15M | $14.44M | $13.61M | $19.00M | $15.60M | $7.00M | $28.97M | $25.82M | $22.38M | $12.16M | $1.16M | $9.47M | $4.31M | $349.91K | $60.84K | $779.43K | $1.12M | $1.18M | $267.06K | $357.57K |
Surprise % | - | - | - | 4.79% | 1.18% | -0.09% | 0.82% | 0.97% | 1.00% | 1.32% | 1.04% | 1.09% | 2.06% | 0.56% | 0.66% | 0.76% | 0.96% | 7.55% | 1.05% | 2.06% | 20.55% | 49.54% | 4.09% | 1.65% | 1.54% | 5.16% | 2.86% |
Forecast
Omeros EPS Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | Sep 09 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | 16 | 10 | 9 | 9 | 13 | 9 | 9 | 15 | 9 | 9 | 16 | 8 | 10 | 16 | 18 | 19 | 8 | 8 | 13 | 14 | 16 | 11 | 11 | 16 |
EPS | - | - | - | $0.53 | $-0.60 | $-1.76 | $-0.36 | $-0.46 | $-0.57 | $-0.60 | $-0.66 | $-0.61 | $-0.53 | $-0.58 | $-0.33 | $-0.29 | $-0.50 | $-0.62 | $-0.34 | $-0.54 | $-0.51 | $-0.54 | $-0.40 | $-0.40 | $-0.30 | $-0.31 | $-1.34 |
Avg Forecast | $-0.76 | $-0.70 | $-1.14 | $-0.56 | $-0.66 | $0.18 | $-0.47 | $-0.58 | $-0.53 | $-0.69 | $-0.49 | $-0.59 | $-0.34 | $-0.40 | $-0.38 | $-0.46 | $-0.42 | $-0.62 | $-0.38 | $-0.32 | $-0.75 | $-0.36 | $-0.38 | $-0.37 | $-0.48 | $-0.29 | $-0.41 |
High Forecast | $-0.54 | $-0.70 | $-1.14 | $-0.56 | $-0.66 | $0.18 | $-0.47 | $-0.58 | $-0.53 | $-0.69 | $-0.49 | $-0.59 | $-0.34 | $-0.40 | $-0.38 | $-0.46 | $-0.42 | $-0.50 | $-0.30 | $-0.26 | $-0.60 | $-0.29 | $-0.30 | $-0.30 | $-0.38 | $-0.23 | $-0.33 |
Low Forecast | $-0.99 | $-0.70 | $-1.14 | $-0.56 | $-0.66 | $0.18 | $-0.47 | $-0.58 | $-0.53 | $-0.69 | $-0.49 | $-0.59 | $-0.34 | $-0.40 | $-0.38 | $-0.46 | $-0.42 | $-0.74 | $-0.46 | $-0.38 | $-0.90 | $-0.43 | $-0.46 | $-0.44 | $-0.58 | $-0.35 | $-0.49 |
Surprise % | - | - | - | -0.95% | 0.91% | -9.71% | 0.76% | 0.80% | 1.08% | 0.87% | 1.36% | 1.04% | 1.56% | 1.45% | 0.87% | 0.63% | 1.18% | 1.00% | 0.89% | 1.69% | 0.68% | 1.50% | 1.05% | 1.08% | 0.63% | 1.07% | 3.27% |
Forecast
Omeros Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ENTA | Enanta Pharmaceuticals | $6.13 | $65.67 | 971.29% | Buy |
PASG | Passage Bio | $0.67 | $6.00 | 795.52% | Buy |
BMEA | Biomea Fusion | $4.64 | $23.33 | 402.80% | Buy |
GOSS | Gossamer Bio | $0.87 | $3.75 | 331.03% | Buy |
ORIC | ORIC Pharmaceuticals | $8.25 | $20.00 | 142.42% | Buy |
STOK | Stoke Therapeutics | $12.10 | $26.50 | 119.01% | Buy |
ARQT | Arcutis Biotherapeutics | $14.86 | $31.00 | 108.61% | Buy |
DAWN | Day One Biopharmaceuticals | $12.64 | $24.00 | 89.87% | Buy |
RNA | Avidity Biosciences | $32.74 | $59.00 | 80.21% | Buy |
AKRO | Akero Therapeutics | $30.61 | $50.00 | 63.35% | Buy |
DSGN | Design Therapeutics | $6.25 | $9.67 | 54.72% | Buy |
LYEL | Lyell Immunopharma | $0.65 | $1.00 | 53.85% | Hold |
FOLD | Amicus Therapeutics | $9.89 | $15.00 | 51.67% | Buy |
RVMD | Revolution Medicines | $45.16 | $65.67 | 45.42% | Buy |
CNTB | Connect Biopharma | $1.06 | $1.50 | 41.51% | Buy |
PTGX | Protagonist Therapeutics | $40.69 | $57.33 | 40.89% | Buy |
MIRM | Mirum Pharmaceuticals | $42.65 | $57.00 | 33.65% | Buy |
CRNX | Crinetics Pharmaceuticals | $55.37 | $69.00 | 24.62% | Buy |
LGND | Ligand Pharmaceuticals | $120.43 | $140.50 | 16.67% | Buy |
OMER | Omeros | $7.88 | $2.00 | -74.62% | Hold |